REGENXBIO to Participate in Upcoming Investor Conferences
REGENXBIO (Nasdaq: RGNX) announced its participation in two key investor conferences in March 2023.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
REGENXBIO (Nasdaq: RGNX) announced its participation in two key investor conferences in March 2023. The Barclays Global Healthcare Conference is scheduled for March 15 at 5:00 p.m. ET in Miami, FL, featuring a fireside chat. Additionally, the company will participate in the BMO Biopharma Spotlight Series on March 28 at 9:00 a.m. ET, focusing on novel genetic medicine delivery technologies in a virtual format. Investors can access a live webcast of the Barclays event on the REGENXBIO website, with an archived replay available for 30 days following the presentation.
Details
News Market Reaction – RGNX
The recorded move for RGNX in the trading session of this news was -2.01%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Fireside Chat Date:
Fireside
Location:
BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of
Panel Date: Tuesday, March 28, 2023
Panel Time: 9:00 a.m. ET
Location: Virtual
A live webcast of the presentation at the
About
Contacts:
Corporate Communications
dcormack@regenxbio.com
Investors:
339-970-2843
chris.brinzey@westwicke.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-301765374.html
SOURCE
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.